The disease course in microscopic colitis may be influenced by hormonal factors
- PMID: 40537741
- PMCID: PMC12180190
- DOI: 10.1186/s12876-025-04083-8
The disease course in microscopic colitis may be influenced by hormonal factors
Abstract
Background: Microscopic colitis (MC) is characterized by non-bloody, watery diarrhea predominantly in elderly women. Known risk factors are smoking, medication with NSAIDs, PPIs or SSRIs, while data on hormonal factors is sparse. The aim of the present study was to investigate whether hormonal factors that disrupt the sex hormonal balance could have an impact on the disease course in MC.
Methods: A questionnaire was distributed to 384 women with microscopic colitis (MC) (mean age 64 years, range 35-90) from five centers in Sweden about demographic aspects including age at diagnosis, disease duration, treatment, and polycystic ovary syndrome, endometriosis, bilateral oophorectomy, previous or ongoing medication with hormones or in vitro fertilization (IVF) in relation to the disease course.
Results: The association with smoking could be verified. In relation to the disease course the odds ratio (OR) was higher for celiac disease and oral contraceptives but lower for hormone replacement therapy but for the two latter non-significant. However, bilateral oophorectomy had a significantly lower OR (0.41, CI 0.19-0.86, p = 0.019). No other factors had any substantial impact on the disease course.
Conclusion: An association was verified with smoking. Celiac disease may be associated with more active disease. The observed lower OR for more active disease after bilateral oophorectomy is in line with a previously suggested association between the risk of MC and the hormonal balance. The exact mechanisms behind the hormonal effect on the disease course found in the present study are although still obscure.
Keywords: Contraceptives; Estrogen; MHT; Microscopic colitis; Oophorectomy; Sex hormones.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study has been carried out in compliance with the Helsinki Declaration and was approved by the Swedish Ethical Review Authority 2019–06338. Written informed consent was obtained from all participating patients before inclusion. All methods used in the study were carried out in accordance with relevant guidelines and regulations. Consent for publication: There is no need to obtain consent from any person in order to be able to publish this article. Competing interests: The authors declare no competing interests.
References
-
- Zheng T, Roda G, Zabana Y, Escudero-Hernández C, Liu X, Chen Y, et al. HLA signatures as pathophysiological discriminants of microscopic colitis subtypes. J Crohns Colitis. 2024;18(3):349–59. 10.1093/ecco-jcc/jjad165. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
